FDA Shares Drug Review Priorities, Sets Date for Public Meeting

FDA Shares Drug Review Priorities, Sets Date for Public Meeting

The FDA recently issued a commitment letter regarding PDUFA VII that spells out its review timeframes, performance goals and modernization priorities for fiscal years 2023-2027 and sets date for public meeting...

September 10, 2021 4:09 PM
Read More +

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

FDA’s Office of Prescription Drug Promotion (OPDP) cited Eton Pharmaceuticals Inc. for presenting benefit information in sponsored links for Alkindi® Sprinkle without including any risk information about the product...

August 30, 2021 10:51 AM
Read More +

PhRMA’s Updated Code for Industry Addresses Speaker Programs, Meals

PhRMA’s Updated Code for Industry Addresses Speaker Programs, Meals

PhRMA's “updated and enhanced” voluntary code of ethics outlines how industry can appropriately interact with HCPs while marketing biopharma products in various ways, including speaker programs...

August 20, 2021 1:57 PM
Read More +

What Biden’s Drug Pricing Plans Could Mean for Biopharma

What Biden’s Drug Pricing Plans Could Mean for Biopharma

President Joe Biden re-emphasized in a televised address last week that he would like Congress to make changes that would allow Medicare to negotiate drug prices to reduce costs for millions of Americans. CHC explains implications for biopharma...

 

August 16, 2021 12:04 PM
Read More +

Recent Posts

OPDP To Study Impact of Exhibit Booth Materials, Medical Conference Conversations on HCPs

07, 29, 2021

Read more

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery

07, 26, 2021

Read more

Colorado Is Third State to Enact Data Privacy Law

07, 19, 2021

Read more

Upcoming Event

{title}

{body}

Read More +

About Us

CHC

CHC

The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the general public receive truthful, accurate information regarding pharmaceuticals, medical products and devices, and patient care.

In addition to white papers and other documents published by the Coalition, you can also find relevant information on current healthcare and health economics issues, as well as policy positions published by government agencies and other professional organizations.